Axon Enterprise, Inc $AXON Stock Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. trimmed its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 27.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,564 shares of the biotechnology company’s stock after selling 1,358 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $1,506,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Verdence Capital Advisors LLC bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $440,000. Flagship Harbor Advisors LLC lifted its stake in Axon Enterprise by 7.7% in the third quarter. Flagship Harbor Advisors LLC now owns 2,576 shares of the biotechnology company’s stock worth $1,088,000 after acquiring an additional 184 shares during the period. Apollon Wealth Management LLC grew its holdings in Axon Enterprise by 1,105.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 147,733 shares of the biotechnology company’s stock worth $62,420,000 after acquiring an additional 135,480 shares in the last quarter. Kingswood Wealth Advisors LLC raised its holdings in shares of Axon Enterprise by 16,593.5% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 110,678 shares of the biotechnology company’s stock valued at $46,764,000 after purchasing an additional 110,015 shares in the last quarter. Finally, Sigma Planning Corp increased its holdings in Axon Enterprise by 30,292.7% during the third quarter. Sigma Planning Corp now owns 184,180 shares of the biotechnology company’s stock valued at $77,820,000 after buying an additional 183,574 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: An analyst opinion upgraded Axon Enterprise to “Buy,” arguing that the company’s valuation premium has narrowed and that its integrated public-safety hardware and cloud-software ecosystem continues to support strong growth. Axon Enterprise: Upgrading To Buy As The Premium Fades
• Positive Sentiment: Recent comparisons with DocuSign, Adobe and Datadog highlighted Axon’s rapid expansion in public safety and its combination of connected devices, software and recurring services. Other coverage also raised the possibility of substantial long-term upside, though these articles were opinion-based rather than new company announcements. Can Axon Stock Jump 50?
• Neutral Sentiment: Investment comparisons positioned Axon as a high-growth public-safety technology company, but offered no new financial results, contracts or guidance that would immediately change earnings expectations. Axon Enterprise vs. DocuSign
• Negative Sentiment: Investors may be reducing exposure before earnings because Zacks said Axon does not appear to have the usual combination of factors supporting a likely earnings beat. That raises the risk of volatility if results or guidance fall short of expectations. Axon Reports Next Week
• Negative Sentiment: Concerns remain that employee share-based compensation taxes are consuming cash despite strong growth, while the stock’s premium valuation leaves limited room for execution errors. Strong Growth, But Staff Share Taxes Eat The Cash
• Negative Sentiment: Axon’s larger decline than the broader market indicates near-term selling pressure, likely reflecting profit-taking and pre-earnings caution rather than a newly announced operational setback. Axon Registers a Bigger Fall Than the Market

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on AXON shares. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Northcoast Research boosted their price objective on shares of Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. Piper Sandler cut their price objective on shares of Axon Enterprise from $732.00 to $561.00 and set an “overweight” rating for the company in a report on Tuesday, October 20th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Finally, Argus raised their price objective on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $688.38.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $427.77 on Monday. The company has a market cap of $34.75 billion, a P/E ratio of 177.50, a P/E/G ratio of 8.13 and a beta of 1.44. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $749.96. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The stock has a 50-day moving average of $463.44 and a two-hundred day moving average of $481.21.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter last year, the company posted $2.12 EPS. The firm’s revenue was up 35.3% compared to the same quarter last year. As a group, analysts anticipate that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Insider Activity at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider directly owned 56,264 shares in the company, valued at approximately $27,032,038.80. This represents a 1.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 47,397 shares of company stock valued at $26,722,984. Corporate insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.